Associations between self-reported SARS-CoV-2 infection status, serology and common longer-term COVID-19 symptoms among adults in Canada, a cross-sectional study.

Abstract

Background: A variety of methods, including self-report and antibody testing, has been used to estimate the prevalence of SARS-CoV-2 infections and related longer-term symptoms, but the impact of employed methods on conclusions has not been thoroughly explored.

Objective: We examined associations between self-report and antibody findings in the Canadian adult (aged 18 years and older) population.

Methods: We used data from a large population-based cross-sectional probability survey conducted between April and August 2022. Self-reported infection status and experiences with common longer-term COVID-19 symptoms since the start of the pandemic was collected, as well as a dried blood spot to measure SARS-CoV-2 antibodies.

Results: As of August 2022, the number of adults reported having had a confirmed or suspected infection was 37.9% (95% CI: 36.8%-39.1%), while the overall mean probability of having infection-related antibodies was 52.9% (95% CI: 51.8%-54.0%) and increased with respondent certainty they had been infected. However, the mean probability of having infection-related antibodies was not associated with infection severity or the reporting of common longer-term COVID-19 symptoms. More than one in five adults were unaware they had been infected.

Conclusion: Self-report surveys may misclassify the SARS-CoV-2 infection status of a substantial proportion of untested people and may bias estimates of the percentage infected, the severity of infections and the risk of developing infection-related longer-term symptoms. Common longer-term COVID-19 symptoms reported by some could have been caused by other infections or diseases.